Treatment sequencing for intracardiac masses in pregnancy: a 10-year retrospective cohort of 21 patients

Abstract Background Intracardiac masses during pregnancy are rare, and treatment decisions must balance timely maternal surgery against fetal exposure to cardiopulmonary bypass (CPB). We evaluated a 10-year single-center experience, focusing on gestational-age-based treatment sequencing and maternal and pregnancy outcomes. Methods We retrospectively reviewed 21 women who underwent surgery for an intracardiac mass associated with pregnancy between April 2016 and July 2026. Strategies were classified by actual sequence: antenatal surgery with intended pregnancy continuation, delivery followed by cardiac surgery during the same anesthetic session, postpartum cardiac surgery, and concurrent early-pregnancy termination and surgery. Follow-up ended on 31 August 2026. Analyses were descriptive. Results Histopathology showed 19 myxomas, 1 hemangioma, and 1 lipoma. Antenatal surgery with intended pregnancy continuation was performed in 14 women at 15.8 ± 3.4 gestational weeks; delivery-prioritized management in 4 at 35–39 weeks; postpartum surgery in 2 at 49 and 57 days after delivery; and concurrent termination and surgery in 1 at 9 weeks. Mean CPB time was 55.9 ± 17.9 min; mean aortic cross-clamp time was 34.2 ± 16.1 min among 20 patients who underwent cross-clamping. There were 17 live births (81.0%), 3 terminations (14.3%), and 1 ongoing pregnancy (4.8%). No in-hospital maternal death or predefined major maternal perioperative complication occurred. Median maternal follow-up was 23.9 months (range, 1.3–124.1), with no death or tumor recurrence documented. Conclusions Individualized sequencing of cardiac surgery and delivery was associated with favorable observed outcomes in this selected surgical cohort. Antenatal resection may be considered before fetal maturity when maternal risk precludes waiting, whereas delivery before cardiac surgery may be appropriate near fetal maturity. These findings support multidisciplinary planning in experienced centers, while conclusions remain constrained by the observational design and small sample size.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-11
DOI
https://doi.org/10.21203/rs.3.rs-10981961/v1
Primary Topic
Cardiac tumors and thrombi
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Treatment sequencing for intracardiac masses in pregnancy: a 10-year retrospective cohort of 21 patients

Yipeng Ge, 乔志钰, Qianqian Wang, Junming Zhu et al.
Research Square
Cardiac tumors and thrombi
preprint

Treatment sequencing for intracardiac masses in pregnancy: a 10-year retrospective cohort of 21 patients

Yipeng Ge, 乔志钰, Qianqian Wang, Junming Zhu, Yi Yang, Haiou Hu, Chengnan Li
preprint en

Abstract

Abstract Background Intracardiac masses during pregnancy are rare, and treatment decisions must balance timely maternal surgery against fetal exposure to cardiopulmonary bypass (CPB). We evaluated a 10-year single-center experience, focusing on gestational-age-based treatment sequencing and maternal and pregnancy outcomes. Methods We retrospectively reviewed 21 women who underwent surgery for an intracardiac mass associated with pregnancy between April 2016 and July 2026. Strategies were classified by actual sequence: antenatal surgery with intended pregnancy continuation, delivery followed by cardiac surgery during the same anesthetic session, postpartum cardiac surgery, and concurrent early-pregnancy termination and surgery. Follow-up ended on 31 August 2026. Analyses were descriptive. Results Histopathology showed 19 myxomas, 1 hemangioma, and 1 lipoma. Antenatal surgery with intended pregnancy continuation was performed in 14 women at 15.8 ± 3.4 gestational weeks; delivery-prioritized management in 4 at 35–39 weeks; postpartum surgery in 2 at 49 and 57 days after delivery; and concurrent termination and surgery in 1 at 9 weeks. Mean CPB time was 55.9 ± 17.9 min; mean aortic cross-clamp time was 34.2 ± 16.1 min among 20 patients who underwent cross-clamping. There were 17 live births (81.0%), 3 terminations (14.3%), and 1 ongoing pregnancy (4.8%). No in-hospital maternal death or predefined major maternal perioperative complication occurred. Median maternal follow-up was 23.9 months (range, 1.3–124.1), with no death or tumor recurrence documented. Conclusions Individualized sequencing of cardiac surgery and delivery was associated with favorable observed outcomes in this selected surgical cohort. Antenatal resection may be considered before fetal maturity when maternal risk precludes waiting, whereas delivery before cardiac surgery may be appropriate near fetal maturity. These findings support multidisciplinary planning in experienced centers, while conclusions remain constrained by the observational design and small sample size.

Research Square
Capital Medical University (CN), Beijing Anzhen Hospital (CN)
Cardiac tumors and thrombi
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon